QuidelOrtho Corp.’s stock lost about a third of its value Wednesday after the diagnostic-products manufacturer missed its fourth-quarter profit estimate, announced job cuts, and sustained at least one analyst downgrade.
San Diego-based QuidelOrtho QDEL reported that its fourth quarter point-of-care revenues and molecular revenue both fell 42% due to COVID-19 headwinds, as the impact of the disease tapered off.
The…
Master your money.
Subscribe to MarketWatch.
Get this article and all of MarketWatch.
Access from any device. Anywhere. Anytime.
Already a subscriber?
Log In
